The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 29, 2025
Filed:
Oct. 17, 2019
Suven Life Sciences Limited, Hyderabad-Telangana, IN;
Ramakrishna Nirogi, Hyderabad, IN;
Abdul Rasheed Mohammed, Hyderabad, IN;
Anil Karbhari Shinde, Hyderabad, IN;
Venkata Ramalingayya Grandhi, Hyderabad, IN;
Pradeep Jayarajan, Hyderabad, IN;
Vijay Benade, Hyderabad, IN;
Gopinadh Bhyrapuneni, Hyderabad, IN;
Venkateswarlu Jasti, Hyderabad, IN;
SUVEN LIFE SCIENCES LIMITED, Hyderabad-Telangana, IN;
Abstract
The present invention relates to new uses of a 5-HTreceptor agonist, specifically Isopropyl-3-{5-[1-(3-methoxypropyl)piperidin-4-yl]-[1,3,4]oxadiazol-2-yl}-1H-indazole (Compound-1) or a pharmaceutically acceptable salts thereof, for the treatment of dementia due to menopause, senile dementia, cognitive deficits associated with schizophrenia, depression, chemotherapy-induced cognitive impairment, and behavioral and psychological symptoms of dementia such as apathy/indifference, agitation, aggression, depression, anxiety, irritability/lability, dysphoria, aberrant motor behavior, delusions, hallucinations, elation/euphoria, psychosis, disinhibition, sleep and night time behavior disorders or appetite and eating disorders. The present invention further provides use of the 5-HT4 receptor agonist in the manufacture of medicament intended for the treatment of the disorders described herein.